Creative Planning’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-85,626
Closed -$2.13M – 4421
2026
Q2
$2.13M Buy
85,626
+15,893
+23% +$372K ﹤0.01% 2034
2026
Q1
$977K Buy
69,733
+4,849
+7% +$65.3K ﹤0.01% 2489
2025
Q4
$729K Sell
64,884
-27,153
-30% -$311K ﹤0.01% 2531
2025
Q3
$1.06M Buy
92,037
+56,756
+161% +$665K ﹤0.01% 2053
2025
Q2
$432K Buy
35,281
+23,745
+206% +$299K ﹤0.01% 2600
2025
Q1
$165K Buy
11,536
+9,743
+543% +$152K ﹤0.01% 3138
2024
Q4
$28.5K Buy
+1,793
New +$35.5K ﹤0.01% 3302
2023
Q4
– Sell
-251
Closed -$5.08K – 2773
2023
Q3
$5.08K Buy
+251
New +$5.69K ﹤0.01% 2714
2022
Q2
– Sell
-30
Closed -$1K – 2289
2022
Q1
$1K Buy
+30
New +$966 ﹤0.01% 2315
2018
Q4
– Sell
-4,252
Closed -$291K – 1959
2018
Q3
$291K Sell
4,252
-1
-0% -$64 ﹤0.01% 1420
2018
Q2
$243K Sell
4,253
-502
-11% -$26.5K ﹤0.01% 1501
2018
Q1
$219K Sell
4,755
-139
-3% -$6.6K ﹤0.01% 1548
2017
Q4
$226K Sell
4,894
-824
-14% -$37.9K ﹤0.01% 1519
2017
Q3
$257K Sell
5,718
-183
-3% -$7.81K ﹤0.01% 1436
2017
Q2
$232K Buy
5,901
+222
+4% +$8.39K ﹤0.01% 1432
2017
Q1
$216K Buy
5,679
+830
+17% +$32.3K ﹤0.01% 1436
2016
Q4
$179K Buy
4,849
+253
+6% +$9.04K ﹤0.01% 1461
2016
Q3
$159K Sell
4,596
-80
-2% -$2.8K ﹤0.01% 1542
2016
Q2
$152K Sell
4,676
-242
-5% -$7.41K ﹤0.01% 1408
2016
Q1
$141K Sell
4,918
-1,167
-19% -$31.1K ﹤0.01% 1418
2015
Q4
$203K Buy
6,085
+1,740
+40% +$54.1K ﹤0.01% 1189
2015
Q3
$124K Buy
+4,345
New +$152K ﹤0.01% 1468
2015
Q2
– Sell
-8,524
Closed -$419K – 1239
2015
Q1
$419K Buy
8,524
+4,086
+92% +$189K ﹤0.01% 813
2014
Q4
$202K Buy
+4,438
New +$174K ﹤0.01% 1131

Other funds holding AVNS

Creative Planning's AVNS Position: Q3 2026 in Review

Creative Planning sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 85,626 shares — an estimated $2.13M sold.

Creative Planning first reported a position in AVNS in Q4 2014 and held it in 24 quarters. The position peaked at $2.13M in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Creative Planning reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Creative Planning sold 85,626 Avanos Medical shares in Q3 2026, an estimated $2.13M.
  • Creative Planning first reported a position in Avanos Medical in Q4 2014 and held it in 24 quarters.
  • Creative Planning's Avanos Medical position peaked at $2.13M in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.